Kornblau SM - Search Results

1

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target.

Alatrash G, Garber HR, Zhang M, Sukhumalchandra P, Qiu Y, Jakher H, Perakis AA, Becker L, Yoo SY, Dwyer KC, Coombes K, Talukder AH, John LSS, Senyukov V, Lee DA, Sergeeva A, He H, Ma Q, Armistead PM, Roszik J, Mittendorf EA, Molldrem JJ, Hawke D, Lizee G, Kornblau SM. Alatrash G, et al. Among authors: kornblau sm. Leukemia. 2017 Jan;31(1):234-237. doi: 10.1038/leu.2016.249. Epub 2016 Aug 30. Leukemia. 2017. PMID: 27573556 Free PMC article. No abstract available.

2

Treatment of myelodysplastic syndromes with AML-type chemotherapy.

Estey E, Pierce S, Kantarjian H, O'Brien S, Beran M, Andreeff M, Escudier S, Koller C, Kornblau S, Robertson L, et al. Estey E, et al. Leuk Lymphoma. 1993;11 Suppl 2:59-63. doi: 10.3109/10428199309064263. Leuk Lymphoma. 1993. PMID: 7510196 Clinical Trial. No abstract available.

3

Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance.

Kornblau SM, Thall P, Huh YO, Estey E, Andreeff M. Kornblau SM, et al. Leukemia. 1995 Oct;9(10):1735-41. Leukemia. 1995. PMID: 7564518

4

Growth-factor stimulation reveals two mechanisms of retinoblastoma gene inactivation in human myelogenous leukemia cells.

Zhang W, Xu HJ, Kornblau SM, Drach J, Hu SX, Andreeff M, Benedict WF, Deisseroth AB. Zhang W, et al. Among authors: kornblau sm. Leuk Lymphoma. 1995 Jan;16(3-4):191-8. doi: 10.3109/10428199509049757. Leuk Lymphoma. 1995. PMID: 7719226

5

Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia.

Kornblau SM, Cortes-Franco J, Estey E. Kornblau SM, et al. Leukemia. 1993 Mar;7(3):378-83. Leukemia. 1993. PMID: 8445943

6

The gene product of CBFB-MYH11.

Claxton D, Xie QS, Patel S, Deisseroth AB, Kornblau S. Claxton D, et al. Leukemia. 1996 Sep;10(9):1479-85. Leukemia. 1996. PMID: 8751466

7

Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.

Kornblau SM, Gandhi V, Andreeff HM, Beran M, Kantarjian HM, Koller CA, O'Brien S, Plunkett W, Estey E. Kornblau SM, et al. Leukemia. 1996 Oct;10(10):1563-9. Leukemia. 1996. PMID: 8847890 Clinical Trial.

8

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.

Sacchi S, Kantarjian HM, O'Brien S, Beran M, Koller C, Pierce S, Kornblau S, Estey E, Keating MJ, Talpaz M. Sacchi S, et al. Leukemia. 1997 Oct;11(10):1610-6. doi: 10.1038/sj.leu.2400791. Leukemia. 1997. PMID: 9324278 Clinical Trial.

9

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

Kantarjian HM, O'Brien SM, Keating M, Beran M, Estey E, Giralt S, Kornblau S, Rios MB, de Vos D, Talpaz M. Kantarjian HM, et al. Among authors: kornblau s. Leukemia. 1997 Oct;11(10):1617-20. doi: 10.1038/sj.leu.2400796. Leukemia. 1997. PMID: 9324279 Clinical Trial.

10

Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.

Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M. Estey E, et al. Leukemia. 1997 Oct;11(10):1661-4. doi: 10.1038/sj.leu.2400783. Leukemia. 1997. PMID: 9324286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page